-----can you imagine what the sales would be for BoneScalpel if you had a large experienced sales force in place currently? The only question right now is just how much the BIGS would pay for that product line. The $100 million mark sounds about right at this time IMO.
If total company revenues in fiscal 2014 (commences July 1 2013) were to come in around $20 Million
a potential acquirer might very well pay 5 times which would get to your $100 million number.
This would work out to approx $12.50 per share ---assuming 8 million shares outstanding
including options---not sure how many options are out there--need to check 10k--
Still, plenty of risks---everyone needs to do own due diligence-